At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Robotic-assisted mini-PCNLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Operative Outcomes Following the Treatment of Kidney Stones With the MONARCH Platform, Urology
In Brief
A clinical study evaluating Robotic-assisted mini-PCNL for Kidney Calculi. Completed, enrolled 15 participants across 2 sites.
Detailed Summary
The purpose of the study is to assess procedural completion, the post-operative stone clearance and the safety profile following robotic mini-Percutaneous Nephrolithotomy (PCNL) performed with the MONARCH Platform, Urology.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Calculi
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartJan 2024
First PostedMar 2024
Primary CompletionDec 2024
Study CompletionMar 2025
TodayJul 2026
First PostedMar 26, 2024
Enrollment StartJan 18, 2024
Primary CompletionDec 23, 2024
Study CompletionMar 11, 2025
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 2.3 years ago
Interventions
Robotic-assisted mini-PCNLdevice
This robotically enabled hybrid procedure called the MONARCH Mini-PCNL will allow the clinician to obtain retrograde and percutaneous access to participant's kidney under continuous visualization for therapeutic applications (i.e., stone removal).